Independent information resource

Services

Wide Anchor 29 offers compact, evidence-first guides for evaluating claims about ibogaine and problematic pornography use. The main claims-versus-evidence overview keeps the question in view: what is known, what is uncertain, and what safety concerns should not be skipped.

  • Evidence before claims
  • Plain-language context
  • Safety awareness
Close view supporting a careful discussion of ibogaine claims and problematic pornography use

Information offerings

Tools for sorting a difficult claim

These are informational services, not clinical care, treatment matching, or medical advice. Our purpose and approach explain the independence and limits behind this material.

01 / Guides

Claim-by-claim guides

Short guides separate claims about ibogaine, behavior change, and pornography use from the evidence needed to support them. For broader substance background, readers can consult the ibogaine information library.

02 / Comparisons

Evidence comparisons

Comparison notes distinguish anecdote, marketing language, observational findings, and clinical research. The clinical-trials overview is useful context when a claim is presented as settled science.

03 / Decision framework

Safety-first questions

Our decision framework makes room for diagnostic uncertainty, contraindications, and the difference between detox claims and behavior-focused claims. The distinction matters when reviewing material about ibogaine treatment for detox.

04 / Glossary & FAQ

Plain-language definitions

A working glossary and FAQ collection clarify terms without implying that a person’s experience has a simple diagnosis or single solution. Background on compulsive sexual behavior disorder helps show why careful language matters.

Visual supporting an evidence-first review of ibogaine claims

Key workflow

Start with the claim, not the promise

Each resource is built to help readers identify what is actually being claimed, what kind of evidence would be relevant, and what remains unknown. Local availability language can easily distract from that question, whether the topic is ibogaine treatment in Texas or a similar location-specific page.

Ibogaine carries meaningful safety concerns. The National Center for Complementary and Integrative Health’s ibogaine overview notes serious risks, including cardiac effects, which is why no information page should present it as a low-stakes answer to a complex concern.

Useful information makes distinctions visible: between a personal story, a research finding, and a conclusion the evidence cannot support.

A practical sequence

Three moves before accepting a claim

Step 01

Name the outcome

Specify whether the claim concerns craving, compulsive behavior, detoxification, mood, or a broad promise of change.

Step 02

Match evidence to outcome

Ask whether the evidence addresses the exact outcome and population being discussed, rather than a different condition or a testimonial.

Step 03

Keep risks in view

Do not let a hoped-for benefit erase practical safety questions, legal context, or the need for qualified professional support where appropriate.

  • IndependentWe do not present ourselves as a clinic or treatment provider.
  • SpecificWe separate an ibogaine claim from evidence about a different outcome.
  • CarefulWe state uncertainty and safety concerns plainly rather than smoothing them over.

FAQ collection

Questions readers bring to the evidence

  1. Does this resource offer ibogaine treatment?

    No. Wide Anchor 29 is an independent information resource. It provides guides, comparisons, and research summaries; it does not provide medical care, treatment placement, or clinical recommendations.

  2. Why include location and product pages?

    They help readers examine common search paths without treating availability as proof. That includes pages about treatment in Oklahoma and information describing ibogaine hydrochloride HCl.

  3. Why is diagnostic language handled carefully?

    Problematic pornography use and compulsive sexual behavior are not interchangeable phrases, and individual experiences vary. The World Health Organization’s CSBD guidance provides useful context for keeping those distinctions clear.